J. Melamed et Wn. Beaucher, MINOR SYMPTOMS ARE NOT PREDICTIVE OF ELEVATED THEOPHYLLINE LEVELS IN ADULTS ON CHRONIC THERAPY, Annals of allergy, asthma, & immunology, 75(6), 1995, pp. 516-520
Background: Theophylline toxicity is associated with significant morbi
dity and mortality. While a relationship of the serum theophylline lev
el to symptoms associated with toxicity has been described in acutely
intoxicated or elderly patients, this relationship may not be valid in
younger patients receiving chronic theophylline therapy. Objective: T
his study was designed to define the predictive value and prevalence o
f minor symptoms of theophylline toxicity in ambulatory asthmatic adul
ts receiving chronic theophylline therapy with elevated serum theophyl
line levels.Methods: We conducted a retrospective study to determine t
he prevalence of symptoms in patients with elevated theophylline level
s (>20 mg/L or 110 mu mol/L). A prospective study was performed to asc
ertain the sensitivity, specificity, and predictive value of symptoms
as an indication of elevated the theophylline level. In addition, we d
escribe a patient who had a seizure in association with an elevated th
eophylline level in the absence of any preceding symptom of theophylli
ne toxicity. Results: We reviewed the result of 483 theophylline measu
rements in 450 asthmatic patients. In 46 instances the theophylline le
vel was >20 mg/L. Only three of these patients were symptomatic. Ninet
y patients were prospectively studied with a total of Ill theophylline
measurements of which 13 exceeded 20 mg/L. None of the symptoms tie,
nausea or gastrointestinal upset; headache or palpitations, irregular
heart beat, tremor, or shakiness) was a sensitive predictor of an elev
ated theophylline level. Conclusions: Elevation of the theophylline le
vel is frequently associated with lack of symptoms in young ambulatory
asthmatic adults receiving chronic theophylline therapy. The question
of whether cardiac or neurologic electrophysiologic abnormalities mig
ht exist in the absence of symptoms is an issue that needs to be addre
ssed. Clinicians should continue to monitor serum levels on a regular
basis and prescribe this drug conservatively.